Table 1.
Prevalence of Chlamydia trachomatis, Neisseria gonorrhea, Mycoplasma genitalium in the 3 types of specimen (Reunion Island, 2014–2015)
| Urogenital specimen | Pharyngeal specimena | Anal specimena | |||||||
|---|---|---|---|---|---|---|---|---|---|
| n/N | P-valuee | Prevalence (95%CId) | n/N | P-valuee | Prevalence (95CI%d) | n/N | P-valuee | Prevalence (95CI%d) | |
| Chlamydia trachomatis infection | |||||||||
| Women ≤25y | 19/186b | 0.02 | 10.21 (6.26–15.49) | 4/141f | 0.12 | 2.83 (0.78–7.10) | 2/36f,h | 0.7 | 5.56 (0.68–18.66) |
| Women >25y | 7/159b | – | 4.40 (1.79–8.86) | 0/134 | – | 0.00 (0.00–2.72) | 0/49 | – | 0.00 (0.00–7.26) |
| MSM | 2/53 | 3.77 (0.46–12.98) | 2/45f | 4.44 (0.54–15.15) | 2/27f,h | 7.41 (0.91–24.29) | |||
| MSW ≤30y | 16/212 | 0.05 | 7.54 (4.37–11.97) | 1/147 | 0.63 | 0.68 (0.02–3.73) | 0/2 | 0.00 (0.00–84.19) | |
| MSW >30y | 4/124 | – | 3.23 (0.89–8.05) | 0/88 | – | 0.00 (0.00–4.11) | 0/1 | 0.00 (0.00–97.50) | |
| Other menc | 2/92 | 2.17 (0.26–7.63) | 1/47 | 2.13 (0.05–11.29) | 0/8 | 0.00 (0.00–36.94) | |||
| Neisseria gonorrhea infection | |||||||||
| Women ≤25y | 2/186 | 0.41 | 1.07 (0.13–3.83) | 0/139 | 0.5 | 0.00 (0.02–2.62) | 0/38 | 0.00 (0.00–9.25) | |
| Women >25y | 1/159 | – | 0.63 (0.01–3.45) | 0/133 | 0.00 (0.00–2.74) | 0/50 | 0.00 (0.00–7.11) | ||
| MSM | 2/53 | 3.77 (0.46–12.98) | 3/44g | 6.81 (1.43–18.66) | 2/27g | 7.40 (0.91–24.29) | |||
| MSW ≤30y | 1/212 | 0.63 | 0.47 (0.01–2.60) | 1/147 | 0.26 | 0.68 (0.02–3.73) | 0/2 | 0.00 (0.00–84.19) | |
| MSW >30y | 0/124 | – | 0.00 (0.00–2.93) | 2/88 | – | 2.27 (0.28–7.97) | 0/1 | 0.00 (0.00–97.50) | |
| Other menc | 0/92 | 0.00 (0.00–3.97) | 0/47 | 0.00 (0.00–7.55) | 0/8 | 0.00 (0.00–36.94) | |||
| Mycoplasma genitalium infection | |||||||||
| Women ≤25y | 5/186 | 0.2 | 2.69 (0.88–6.16) | 1/145 | 0.5 | 0.72 (0.02–4.09) | 0/39 | 0.56 | 0.00 (0.07–9.03) |
| Women >25y | 2/159 | – | 1.26 (0.15–4.47) | 1/134 | – | 0.75 (0.02–4.12) | 1/50 | – | 2.00 (0.05–10.65) |
| MSM | 1/53 | 1.89 (0.05–10.07) | 0/45 | 0.00 (0.00–7.87) | 1/27 | 3.70 (0.09–18.97) | |||
| MSW ≤30y | 5/212 | 0.1 | 2.36 (0.77–5.42) | 0/147 | 0.00 (0.00–2.48) | 0/2 | 0.00 (0.00–84.19) | ||
| MSW >30y | 0/124 | – | 0.00 (0.00–2.93) | 0/88 | 0.00 (0.00–4.11) | 0/1 | 0.00 (0.00–97.50) | ||
| Other menc | 2/92 | 2.17 (0.26–7.63) | 0/47 | 0.00 (0.00–7.55) | 0/8 | 0.00 (0.00–36.94) | |||
aPrevalence of anal and pharyngeal infections without concomitant urogenital CT, NG, or MG infection; y years; bTotal excludes one woman with CT infection for whom age was unknown; MSM men who have sex with men, MSW men who have sex with women; cmen who did not share their sexual orientation; CI confidence interval; dbinomial exact confidence interval; eFisher’s exact test; n: number of positive specimens; N total number of specimens; fTotal includes one specimen with concomitant pharyngeal and anal infections; gTotal includes two patients with concomitant pharyngeal and anal infections; hno anorectitis reported by infected patients